HBV-IN-17

• UNSPSC Description:

  HBV-IN-17 (compound 8) is a potent HBV capsid assembly modulator with an EC50 of 511 nM[1].

• Target Antigen:

  HBV

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/hbv-in-17.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C1=C2CN(C(NC3=CC(F)=C(F)C(F)=C3)=O)CCN2C=N1)N[C@H](C)C(F)(F)F

• Molecular Weight:

  435.32

• References & Citations:

  [1]Li X, et al. Discovery of SHR5133, a Highly Potent and Novel HBV Capsid Assembly Modulator. ACS Med Chem Lett. 2022, 13(3):507-512.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2270943-13-8